Mohsin El Amrani believes 2D-LC with HRAM-MS pave the way for bioanalytical quantification of next-generation therapeutic mAbs

With advancements in MS technology, proteomics has opened the door to a new wealth of possibilities to evolve how we understand and treat diseases

Are some journal editors giving articles preferential treatment for a fee?

Welcome to the challenging, potentially perilous, and (unfortunately) increasingly relevant field of chemical warfare agent analysis

We catch up with The Power List 2018 Top 40 Under 40 finalists – Andrea Gargano talks us through failures, fatherhood and the future…

How DART-MS hits the mark for point-of-need applications

Sitting Down With… Tony Edge, Site Director (Production & R&D), Avantor Sciences, UK

Personalized serology, award-winning advice, and the latest product launches… Check out our highlights from ASMS 2022

2018 Power Lister, Emma Schymanski tells us about the growth of her research team and discusses the H2020 project ZeroPM and FAIR data exchange.

Advanced analytical technologies now offer the detailed assessments biopharma drug developers need.